Tech Company Financing Transactions
Juno Diagnostics Funding Round
On 5/13/2021, Juno Diagnostics announced $25 million in Series A funding from Perceptive Advisors and private investors.
Transaction Overview
Company Name
Announced On
5/13/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Perceptive Advisors (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9191 Towne Centre Dr. 575
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Juno Diagnostics is developing genetic testing solutions to improve access to vital health information. The company's lead product is an NIPT solution that simplifies sample collection and improves access to high quality genetic testing results without the high cost, long lead times, and phlebotomy requirements of traditional NIPT.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dirk van den Boom
Chief Operating Officer
James Chauvapun
Chief Scientific Officer
Mathias Ehrich
Co-Founder
Paul Oeth
Browse more venture capital transactions:
Prev: 5/13/2021: Treasury Prime venture capital transaction
Next: 5/13/2021: Panaseer venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs